While increasing vertical tumor thickness is reported to be associated with poorer prognosis [3], ASC immunoreactivity did not correlate with tumor thickness (Fig 2A) or with its metastatic potential (Table 1). The gene discussed is PYCARD; the disease is neoplasm.